Distribution of FcγRIIa and FcγRIIIa genotypes in vaccinees and placebo recipients
| . | No. vaccinees (%) . | No. placebo recipients (%) . |
|---|---|---|
| FcγRIIa | ||
| RR | 380 (25.7) | 75 (28.9) |
| RH | 754 (50.9) | 126 (48.5) |
| HH | 346 (23.4) | 59 (22.7) |
| Total | 1480 (100) | 260 (100) |
| FcγRIIIa | ||
| FF | 629 (43.4) | 116 (45.0) |
| FV | 644 (44.5) | 108 (41.9) |
| VV | 174 (12.0) | 34 (13.2) |
| Total | 1447 (100) | 258 (100) |
| . | No. vaccinees (%) . | No. placebo recipients (%) . |
|---|---|---|
| FcγRIIa | ||
| RR | 380 (25.7) | 75 (28.9) |
| RH | 754 (50.9) | 126 (48.5) |
| HH | 346 (23.4) | 59 (22.7) |
| Total | 1480 (100) | 260 (100) |
| FcγRIIIa | ||
| FF | 629 (43.4) | 116 (45.0) |
| FV | 644 (44.5) | 108 (41.9) |
| VV | 174 (12.0) | 34 (13.2) |
| Total | 1447 (100) | 258 (100) |
F indicates phenylalanine; FcγR, Fc receptor for IgG; H, histidine; R, arginine; and V, valine.